返回
摘要
En 中文
During the 1990s the focus of group B streptococcus (GBS) disease research has shifted to prevention. increased use of intrapartum antimicrobial prophylaxis in North America and Australia has led to substantial declines in perinatal disease. Vaccine development (initiated two decades earlier) has yielded results-for example, polysaccharide-protein conjugate vaccines given to women of reproductive age proved to be highly immunogenic and well tolerated. Also economic evaluations have assessed the cost-effectiveness of prevention strategies in different populations. Although GBS has traditionally been considered a perinatal pathogen, the burden of invasive GBS disease among nonpregnant adults has been measured. Adverse outcomes of pregnancy attributable to GBS were addressed through a multicentre study which confirmed the important role of heavy colonisation with GBS in preterm low-birthweight deliveries. Finally, the pathogen itself has continued to evolve: new capsular serotypes described in the past decade are now causing an important proportion of clinical infections.
Keyword:
SELECTIVE INTRAPARTUM CHEMOPROPHYLAXIS
VAGINAL CHLORHEXIDINE DISINFECTION
MULTISTATE SURVEILLANCE ANALYSIS
TOXOID CONJUGATE VACCINE
SINGLE-DOSE PENICILLIN
EARLY-ONSET DISEASE
PRETERM DELIVERY
PREGNANT-WOMEN
RISK-FACTORS
VERTICAL TRANSMISSION
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
88.5
论文数:
5.4W
被引数:
34.8W
机构
暂无机构信息
引用论文
Relationship of Cerebellar Purkinje Cell Simple Spike Discharge to Movement Kinematics in the Monkey

